LB1074 Predicting treatment decisions in elderly patients with non-melanoma skin cancers
Over 5.4 million cases of non-melanoma skin cancer (NMSC) arise yearly, primarily in the elderly. In older patients with comorbidities, long-term benefits of treatment must be balanced with short-term risks. As limited life expectancy and Charlson comorbidity index have not been shown to affect treatment decisions, our study aimed to identify specific clinical characteristics differentiating untreated and treated patients among the elderly. We performed a retrospective cross-sectional review of biopsy-proven skin cancers between January 2017 and January 2018 at a single academic center.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: P. Basu, A. Beckles, M.L. Porter, S. Olbricht Tags: Epidemiology Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Dermatology | Epidemiology | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Biopsy | Skin Cancer | Study